$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

디지털 헬스 중재가 지역사회 중증정신질환자의 정신병적 증상에 미치는 효과: 체계적 문헌고찰 및 메타분석
Effect of Digital Health Interventions on Psychotic Symptoms among Persons with Severe Mental Illness in Community: A Systematic Review and Meta-Analysis 원문보기

Journal of Korean academy of nursing = 대한간호학회지, v.53 no.1, 2023년, pp.69 - 86  

오은진 (송원대학교 간호학과) ,  강문희 (충남대학교 간호대학)

Abstract AI-Helper 아이콘AI-Helper

Purpose: This study aimed to evaluate the effects of digital health interventions on the psychotic symptoms among people with severe mental illness in the community. Methods: A systematic review and meta-analysis were conducted in accordance with the Cochrane Intervention Research Systematic Review ...

주제어

참고문헌 (57)

  1. Sullivan SA, Kounali D, Cannon M, David AS, Fletcher PC,?Holmans P, et al. A population-based cohort study examining the incidence and impact of psychotic experiences from?childhood to adulthood, and prediction of psychotic disorder.?The American Journal of Psychiatry. 2020;177(4):308-317.?https://doi.org/10.1176/appi.ajp.2019.19060654 

  2. Yoon SJ, Kim YE, Lee HG, Chung SG, Choi MM, Ha KH, et?al. A survey on the medical system for people with severe and?mental disorders. Seoul: National Human Rights Commission?of Korea; 2019 Dec. Report No.: 11-1620000-000764-01. 

  3. Ruggeri M, Leese M, Thornicroft G, Bisoffi G, Tansella M.?Definition and prevalence of severe and persistent mental?illness. The British Journal of Psychiatry. 2000;177(2):149-155. https://doi.org/10.1192/bjp.177.2.149 

  4. Joa I, Gisselgard J, Bronnick K, McGlashan T, Johannessen?JO. Primary prevention of psychosis through interventions in?the symptomatic prodromal phase, a pragmatic Norwegian?Ultra High Risk study. BMC Psychiatry. 2015;15:89.?https://doi.org/10.1186/s12888-015-0470-5 

  5. Rus-Calafell M, Schneider S. Are we there yet?!-a literature review of recent digital technology advances for the?treatment of early psychosis. Mhealth. 2020;6:3.?https://doi.org/10.21037/mhealth.2019.09.14 

  6. American Psychiatric Association. Diagnostic and statistical?manual of mental disorders: DSM-5. 5th ed. Washington,?DC: American Psychiatric Publishing; 2013. p. 87-122. 

  7. Alvarez-Jimenez M, Priede A, Hetrick SE, Bendall S, Killackey E, Parker AG, et al. Risk factors for relapse following?treatment for first episode psychosis: A systematic review?and meta-analysis of longitudinal studies. Schizophrenia Research. 2012;139(1-3):116-128.?https://doi.org/10.1016/j.schres.2012.05.007 

  8. Ben-Zeev D, Chander A, Tauscher J, Buck B, Nepal S,?Campbell A, et al. A smartphone intervention for people?with serious mental illness: Fully remote randomized controlled trial of CORE. Journal of Medical Internet Research.?2021;23(11):e29201. https://doi.org/10.2196/29201 

  9. World Health Organization (WHO). mhGAP training manuals?for the mhGAP intervention guide for mental, neurological?and substance use disorders in non-specialized health settings, version 2.0 (? for field testing). Geneva: World Health?Organization; 2017. Report No.: WHO/MSD/MER/17.6. 

  10. Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause?M, Samara M, Peter N, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of?adults with multi-episode schizophrenia: A systematic review?and network meta-analysis. Lancet. 2019;394(10202):939-951. https://doi.org/10.1016/S0140-6736(19)31135-3 

  11. Bilder RM, Goldman RS, Volavka J, Czobor P, Hoptman M,?Sheitman B, et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic?schizophrenia or schizoaffective disorder. The American?Journal of Psychiatry. 2002;159(6):1018-1028.?https://doi.org/10.1176/appi.ajp.159.6.1018 

  12. Larson MK, Walker EF, Compton MT. Early signs, diagnosis?and therapeutics of the prodromal phase of schizophrenia and?related psychotic disorders. Expert Review of Neurotherapeutics. 2010;10(8):1347-1359.?https://doi.org/10.1586/ern.10.93 

  13. Guhne U, Weinmann S, Riedel-Heller SG, Becker T. Psychosocial therapies in severe mental illness: Update on evidence and recommendations. Current Opinion in Psychiatry.?2020;33(4):414-421.?https://doi.org/10.1097/YCO.0000000000000618 

  14. Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB;?Schizophrenia Patient Outcomes Research Team (PORT).?The Schizophrenia Patient Outcomes Research Team (PORT):?Updated treatment recommendations 2009. Schizophrenia?Bulletin. 2010;36(1):94-103.?https://doi.org/10.1093/schbul/sbp130 

  15. Lee SY, Chae SM, Jeon JA, Yoon SM, Cha MR, Jung JW, et?al. Strategies for securing the local mental health promotion?service supply system - focusing on the management of severe mental illness in the community. Sejong: Korea Institute?for Health and Social Affairs; 2018 Dec. Report No.: Research Monographs 2018-26. 

  16. Lee YM. National mental health survey. Seoul: National?Center for Mental Health (KR); 2021 Dec. Report No.: 11-1352629-000065-01. 

  17. Corrigan PW, Druss BG, Perlick DA. The impact of mental illness stigma on seeking and participating in mental?health care. Psychological Science in the Public Interest.?2014;15(2):37-70.?https://doi.org/10.1177/1529100614531398 

  18. Murray E, Hekler EB, Andersson G, Collins LM, Doherty A,?Hollis C, et al. Evaluating digital health interventions: Key?questions and approaches. American Journal of Preventive?Medicine. 2016;51(5):843-851.?https://doi.org/10.1016/j.amepre.2016.06.008 

  19. Bell I, Pot-Kolder RMCA, Wood SJ, Nelson B, Acevedo N,?Stainton A, et al. Digital technology for addressing cognitive impairment in recent-onset psychosis: A perspective.?Schizophrenia Research: Cognition. 2022;28:100247.?https://doi.org/10.1016/j.scog.2022.100247 

  20. Moulin T, Dobson J, Hixson JD, Arvanitis TN. Digital Health:?The journal's pioneering journey 6 years on. Digital Health.?2021;7:20552076211034034.?https://doi.org/10.1177/20552076211034034 

  21. Krzystanek M, Borkowski M, Skalacka K, Krysta K. A telemedicine platform to improve clinical parameters in paranoid?schizophrenia patients: Results of a one-year randomized?study. Schizophrenia Research. 2019;204:389-396.?https://doi.org/10.1016/j.schres.2018.08.016 

  22. Garety P, Ward T, Emsley R, Greenwood K, Freeman D,?Fowler D, et al. Effects of SlowMo, a blended digital therapy targeting reasoning, on paranoia among people with?psychosis: A randomized clinical trial. JAMA Psychiatry.?2021;78(7):714-725.?https://doi.org/10.1001/jamapsychiatry.2021.0326 

  23. Dellazizzo L, Potvin S, Phraxayavong K, Dumais A. Oneyear randomized trial comparing virtual reality-assisted?therapy to cognitive-behavioral therapy for patients with?treatment-resistant schizophrenia. NPJ Schizophrenia.?2021;7(1):9. https://doi.org/10.1038/s41537-021-00139-2 

  24. Gottlieb JD, Gidugu V, Maru M, Tepper MC, Davis MJ,?Greenwold J, et al. Randomized controlled trial of an internet?cognitive behavioral skills-based program for auditory hallucinations in persons with psychosis. Psychiatric Rehabilitation?Journal. 2017;40(3):283-292.?https://doi.org/10.1037/prj0000258 

  25. Depp CA, Perivoliotis D, Holden J, Dorr J, Granholm EL.?Single-session mobile-augmented intervention in serious?mental illness: A three-arm randomized controlled trial. Schizophrenia Bulletin. 2019;45(4):752-762.?https://doi.org/10.1093/schbul/sby135 

  26. Marono Souto Y, Vazquez Campo M, Diaz Llenderrozas F,?Rodriguez lvarez M, Mateos R, Garcia Caballero A. Randomized clinical trial with e-MotionalTraining ® 1.0 for social?cognition rehabilitation in schizophrenia. Frontiers in Psychiatry. 2018;9:40. https://doi.org/10.3389/fpsyt.2018.00040 

  27. Cullen BA, Rodriguez K, Eaton WW, Mojtabai R, Von Mach?T, Ybarra ML. Clinical outcomes from the texting for relapse?prevention (T4RP) in schizophrenia and schizoaffective disorder study. Psychiatry Research. 2020;292:113346.?https://doi.org/10.1016/j.psychres.2020.113346 

  28. Naslund JA, Aschbrenner KA. Digital technology for health?promotion: Opportunities to address excess mortality in persons living with severe mental disorders. Evidence Based?Mental Health. 2019;22(1):17-22.?https://doi.org/10.1136/ebmental-2018-300034 

  29. Chivilgina O, Elger BS, Jotterand F. Digital technologies for?schizophrenia management: A descriptive review. Science?and Engineering Ethics. 2021;27(2):25.?https://doi.org/10.1007/s11948-021-00302-z 

  30. Kim SK, Lee M, Jeong H, Jang YM. Effectiveness of mobile?applications for patients with severe mental illness: A meta-analysis of randomized controlled trials. Japan Journal of?Nursing Science. 2022;19(3):e12476.?https://doi.org/10.1111/jjns.12476 

  31. Mohr DC, Azocar F, Bertagnolli A, Choudhury T, Chrisp P,?Frank R, et al.; Banbury Forum on Digital Mental Health.?Banbury forum consensus statement on the path forward?for digital mental health treatment. Psychiatric Services.?2021;72(6):677-683.?https://doi.org/10.1176/appi.ps.202000561 

  32. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T,?Page MJ, et al. Cochrane handbook for systematic reviews of?interventions. 2nd ed. Chichester (WS): John Wiley & Sons;?2019. p. 321-374. 

  33. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann?TC, Mulrow CD, et al. The PRISMA 2020 statement: An?updated guideline for reporting systematic reviews. BMJ.?2021;372:n71. https://doi.org/10.1136/bmj.n71 

  34. Bidwell S, Jensen MF. Etext on health technology assessment?(HTA) information resources. Chapter 3: Using a search protocol to identify sources of information: The COSI model [Internet]. Bethesda: National Library of Medicine (US); c2003?[cited 2022 May 20]. Available from: https://www.nlm.nih.?gov/archive/20060905/nichsr/ehta/chapter3.html#COSI 

  35. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.?https://doi.org/10.1136/bmj.d5928 

  36. Kim SY, Park DA, Seo HJ, Shin SS, Lee SJ, Lee M, et al.?Health technology assessment methodology: Systematic review. Seoul: National Evidence-based Healthcare Collaborating Agency (KR); 2020. p. 131-132. 

  37. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale (NJ): Lawrence Eribaum Associates;?1988. p. 22. 

  38. Bell IH, Rossell SL, Farhall J, Hayward M, Lim MH, Fielding-Smith SF, et al. Pilot randomised controlled trial of a brief?coping-focused intervention for hearing voices blended with?smartphone-based ecological momentary assessment and intervention (SAVVy): Feasibility, acceptability and preliminary?clinical outcomes. Schizophrenia Research. 2020;216:479-487. https://doi.org/10.1016/j.schres.2019.10.026 

  39. Ben-Zeev D, Brian RM, Jonathan G, Razzano L, Pashka N,?Carpenter-Song E, et al. Mobile health (mHealth) versus?clinic-based group intervention for people with serious mental?illness: A randomized controlled trial. Psychiatric Services.?2018;69(9):978-985.?https://doi.org/10.1176/appi.ps.201800063 

  40. Pot-Kolder RMCA, Geraets CNW, Veling W, van Beilen M,?Staring ABP, Gijsman HJ, et al. Virtual-reality-based cognitive behavioural therapy versus waiting list control for paranoid ideation and social avoidance in patients with psychotic?disorders: A single-blind randomised controlled trial. Lancet?Psychiatry. 2018;5(3):217-226.?https://doi.org/10.1016/S2215-0366(18)30053-1 

  41. Lewis S, Ainsworth J, Sanders C, Stockton-Powdrell C,?Machin M, Whelan P, et al. Smartphone-enhanced symptom?management in psychosis: Open, randomized controlled trial.?Journal of Medical Internet Research. 2020;22(8):e17019.?https://doi.org/10.2196/17019 

  42. Craig TK, Rus-Calafell M, Ward T, Leff JP, Huckvale M,?Howarth E, et al. AVATAR therapy for auditory verbal hallucinations in people with psychosis: A single-blind, randomised controlled trial. Lancet Psychiatry. 2018;5(1):31-40. https://doi.org/10.1016/S2215-0366(17)30427-3?Erratum in: Lancet Psychiatry. 2018;5(1):e1. 

  43. Ghaemi SN, Sverdlov O, van Dam J, Campellone T, Gerwien?R. A smartphone-based intervention as an adjunct to standard-of-care treatment for schizophrenia: Randomized controlled trial. JMIR Formative Research. 2022;6(3):e29154.?https://doi.org/10.2196/29154 

  44. Mojtabai R, Fochtmann L, Chang SW, Kotov R, Craig TJ,?Bromet E. Unmet need for mental health care in schizophrenia: An overview of literature and new data from a first-admission study. Schizophrenia Bulletin. 2009;35(4):679-695.?https://doi.org/10.1093/schbul/sbp045 

  45. Cugelman B. Gamification: What it is and why it matters?to digital health behavior change developers. JMIR Serious Games. 2013;1(1):e3. https://doi.org/10.2196/games.3139 

  46. National Collaborating Centre for Mental Health (GB). Psychosis and schizophrenia in adults: Treatment and management. Updated ed. London: National Collaborating Centre for?Mental Health (GB); 2014. p. 221-222. 

  47. Jauhar S, Laws KR, McKenna PJ. CBT for schizophrenia: A?critical viewpoint. Psychological Medicine. 2019;49(8):1233-?1236. https://doi.org/10.1017/S0033291718004166 

  48. Bighelli I, Salanti G, Huhn M, Schneider-Thoma J, Krause?M, Reitmeir C, et al. Psychological interventions to reduce?positive symptoms in schizophrenia: Systematic review and?network meta-analysis. World Psychiatry. 2018;17(3):316-329. https://doi.org/10.1002/wps.20577 

  49. Killaspy H, Harvey C, Brasier C, Brophy L, Ennals P,?Fletcher J, et al. Community-based social interventions for?people with severe mental illness: A systematic review and?narrative synthesis of recent evidence. World Psychiatry.?2022;21(1):96-123. https://doi.org/10.1002/wps.20940 

  50. Alvarez-Jimenez M, Alcazar-Corcoles MA, Gonzalez-Blanch?C, Bendall S, McGorry PD, Gleeson JF. Online, social media?and mobile technologies for psychosis treatment: A systematic review on novel user-led interventions. Schizophrenia?Research. 2014;156(1):96-106.?https://doi.org/10.1016/j.schres.2014.03.021 

  51. Torous J, Bucci S, Bell IH, Kessing LV, Faurholt-Jepsen M,?Whelan P, et al. The growing field of digital psychiatry: Current evidence and the future of apps, social media, chatbots,?and virtual reality. World Psychiatry. 2021;20(3):318-335.?https://doi.org/10.1002/wps.20883 

  52. Ben-Zeev D, Brenner CJ, Begale M, Duffecy J, Mohr DC,?Mueser KT. Feasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophrenia. Schizophrenia Bulletin. 2014;40(6):1244-1253.?https://doi.org/10.1093/schbul/sbu033 

  53. Torous J, Nicholas J, Larsen ME, Firth J, Christensen H.?Clinical review of user engagement with mental health smartphone apps: Evidence, theory and improvements. Evidence?Based Mental Health. 2018;21(3):116-119.?https://doi.org/10.1136/eb-2018-102891 

  54. Steare T, O'Hanlon P, Eskinazi M, Osborn D, Lloyd-Evans B,?Jones R, et al. Smartphone-delivered self-management for?first-episode psychosis: The ARIES feasibility randomised?controlled trial. BMJ Open. 2020;10(8):e034927.?https://doi.org/10.1136/bmjopen-2019-034927 

  55. Hansson L, Hedner T, Dahlof B. Prospective randomized?open blinded end-point (PROBE) study. A novel design for?intervention trials. Prospective Randomized Open Blinded?End-Point. Blood Pressure. 1992;1(2):113-119.?https://doi.org/10.3109/08037059209077502 

  56. Sverdlov O, van Dam J, Hannesdottir K, Thornton-Wells T.?Digital therapeutics: An integral component of digital innovation in drug development. Clinical Pharmacology and Therapeutics. 2018;104(1):72-80.?https://doi.org/10.1002/cpt.1036 

  57. Kim SY, Park DA, Seo HJ, Shin SS, Lee SJ, Lee M, et al.?Health technology assessment methodology: Systematic review. Seoul: National Evidence-based Healthcare Collaborating Agency (KR); 2020. p. 140. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로